Friday, December 02, 2016 10:00:57 PM
October 30, 2016, By OwnTheFloat |
This is obviously a pure speculation / hypothetical article. There’s absolutely no public evidence available right now that suggests OWCP is currently being considered by Big Pharma, but we know TEVA was interested in July 2015. We also know, by an easy Google search, that many Big Pharma companies are looking to spend money on acquisitions. Merck and Novartis are two of many. In fact, Novartis has up to $5 Billion burning a hole in it’s pocket, apparently.
Cynapsus Therapeutics Inc. (CYNA), a company focusing on Parkinson’s Disease, was acquired for $635 million. They have no revenue.
Pfizer acquired Medivation for $14 Billion this year, but they had about $2 Billion in revenue.
Cinven acquired a pharmaceutical research company, BioClinica, earlier this year as well for $1.4 Billion.
You get the point. There are a lot of acquisitions taking place all the time. With the news and updates we’re getting from OWCP, it feels like it’s only a matter of time until they receive another acquisition offer. That doesn’t mean Ziv Turner and crew will accept, however.
We all know based on simple comparisons of company type, Market Value, etc. that OWCP should be trading between $0.50 – $1.00 per share right now. Maybe after more US states legalize Marijuana for medical, we’ll see a tremendous surge in share price in just a week or two. It happened back in 2012.
If you want to day dream a little about what your shares are worth with an acquisition scenario, simply take the Buyout Value divided by the number of Outstanding Shares (around 135.5 million as of 10/30/16). For example: If Merck were to offer $1.0 Billion for OWCP, we’d expect around $7.38 per share. Don’t want to go overboard? How about $500 million? That’s still $3.69 per share. Still pretty sweet, right?
For What It’s Worth:
‘Investo7’ on iHub reminded us all about VRML’s run from $0.048 to $1.29 on Friday, September 11th, 2009 with a News Release about the FDA clearing a test for Ovarian Cancer. VRML continued to climb as high as $3.08 the following Monday, $14.00 within a week, and $20.00 after a month. Rumors of a buy out lead the stock all the way to $34.00 within 6 months.
$0.048 to $34.00 in 6 months. Tell me again why OWCP can’t run from $0.17 to $8.00 when products come to market in early 2017
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM